BioAtla Inc (BCAB)

Name: BioAtla Inc Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$0.0

Net Income

$0.0

Operating Margin

N/A

Free Cash Flow

-$48.2M

Debt / Assets

72.8%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for BioAtla Inc (BCAB).
Income Statement (Quarterly)	2026-03-31	2025-03-31	2024-12-31	2024-09-30
Revenue	0	0	0	11,000,000
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	11,000,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	4,726,000	5,259,000	4,594,000	5,875,000
Operating Expenses	9,308,000	17,614,000	16,244,000	22,270,000
Operating Income	-9,308,000	-17,614,000	-16,244,000	-11,270,000
Interest Expense	0	0	0	0
Income Before Tax	0	-15,334,000	-14,884,000	-10,586,000
Income Tax Expense	0	0	0	0
Net Income	0	-15,334,000	-14,884,000	-10,586,000
Per Share
EPS	-4.22	-0.26	-0.31	-0.22
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for BioAtla Inc (BCAB).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	2,000,000	11,000,000	0	0	250,000
Cost of Revenue	0	925,000	1,221,000	1,199,000	0
Gross Profit	2,000,000	10,075,000	-103,731,000	-1,199,000	250,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	17,732,000	21,848,000	25,956,000	28,793,000	38,416,000
Operating Expenses	61,305,000	84,018,000	129,687,000	108,140,000	96,690,000
Operating Income	-59,305,000	-73,943,000	-129,687,000	-108,140,000	-96,440,000
Interest Expense	0	0	0	-1,658,000	-3,000
Income Before Tax	-59,607,000	-69,776,000	-123,462,000	-106,482,000	0
Income Tax Expense	0	0	0	-1,199,000	0
Net Income	-59,607,000	-69,776,000	-123,462,000	-105,283,000	0
Per Share
EPS	-50.50	-1.44	-2.58	-2.70	0.00
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for BioAtla Inc (BCAB).
Balance Sheet (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	49,046,000	111,471,000	215,507,000	244,979,000
Short Term Investments	0	0	0	0
Net Receivables	0	0	0	0
Inventory	0	0	0	0
Total Current Assets	51,232,000	116,406,000	220,431,000	247,292,000
Property Plant Equipment	1,190,000	3,098,000	5,151,000	6,976,000
Goodwill and Intangibles	0	0	0	0
Total Assets	52,422,000	119,658,000	225,736,000	254,422,000
Liabilities
Account Payables	1,902,000	3,819,000	4,231,000	0
Short Term Debt	836,000	3,248,000	1,521,000	6,760,000
Total Current Liabilities	14,540,000	28,344,000	23,131,000	19,813,000
Long Term Debt	0	1,672,000	2,460,000	3,982,000
Total Liabilities	38,157,000	48,986,000	45,397,000	43,601,000
Shareholders Equity
Retained Earnings	-486,039,000	-416,263,000	-292,801,000	-186,319,000
Total Shareholders Equity	14,265,000	70,672,000	180,339,000	210,821,000

Balance sheet annual history for BioAtla Inc (BCAB).
Balance Sheet (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	49,046,000	111,471,000	215,507,000	244,979,000	238,605,000
Short Term Investments	0	0	0	0	0
Net Receivables	0	0	0	0	0
Inventory	0	0	0	0	0
Total Current Assets	51,232,000	116,406,000	220,431,000	247,292,000	240,681,000
Property Plant Equipment	1,190,000	3,098,000	5,151,000	6,976,000	4,102,000
Goodwill and Intangibles	0	0	0	0	0
Total Assets	52,422,000	119,658,000	225,736,000	254,422,000	244,937,000
Liabilities
Account Payables	1,902,000	3,819,000	4,231,000	0	2,456,000
Short Term Debt	836,000	3,248,000	1,521,000	6,760,000	0
Total Current Liabilities	14,540,000	28,344,000	23,131,000	19,813,000	32,261,000
Long Term Debt	0	1,672,000	2,460,000	3,982,000	682,000
Total Liabilities	38,157,000	48,986,000	45,397,000	43,601,000	34,963,000
Shareholders Equity
Retained Earnings	-486,039,000	-416,263,000	-292,801,000	-186,319,000	-90,917,000
Total Shareholders Equity	14,265,000	70,672,000	180,339,000	210,821,000	209,974,000

Cash flow quarterly history for BioAtla Inc (BCAB).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	-59,607,000	-69,776,000	-123,462,000	-106,482,000
Depreciation & Amortization	373,000	925,000	1,221,000	1,199,000
Stock Based Compensation	5,434,000	8,921,000	13,544,000	14,563,000
Change in Working Capital	4,276,000	-11,199,000	4,680,000	287,000
Operating Cash Flow	-48,204,000	-71,936,000	-104,015,000	-90,420,000
Investing Activities
Capital Expenditure	0	0	-98,000	-268,000
Investments	0	0	-98,000	-268,000
Investing Cash Flow	0	0	-98,000	-265,000
Financing Activities
Debt Repayment	7,125,000	0	0	0
Common Stock Issued/Repurchased	100,000	9,215,000	335,741	61,971,000
Dividends Paid	0	0	0	0
Financing Cash Flow	6,276,000	9,511,000	77	61,213,000
Summary
Free Cash Flow	-48,204,000	-71,936,000	-104,113,000	-90,688,000
Net Change in Cash	-41,928,000	-62,425,000	-104,036,000	-29,472,000

Cash flow annual history for BioAtla Inc (BCAB).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-59,607,000	-69,776,000	-123,462,000	-106,482,000	0
Depreciation & Amortization	373,000	925,000	1,221,000	1,199,000	1,330,000
Stock Based Compensation	5,434,000	8,921,000	13,544,000	14,563,000	25,117,000
Change in Working Capital	4,276,000	-11,199,000	4,680,000	287,000	7,424,000
Operating Cash Flow	-48,204,000	-71,936,000	-104,015,000	-90,420,000	-62,214,000
Investing Activities
Capital Expenditure	0	0	-98,000	-268,000	-924,000
Investments	0	0	-98,000	-268,000	-924,000
Investing Cash Flow	0	0	-98,000	-265,000	-924,000
Financing Activities
Debt Repayment	7,125,000	0	0	0	0
Common Stock Issued/Repurchased	100,000	9,215,000	335,741	61,971,000	71,283,000
Dividends Paid	0	0	0	0	0
Financing Cash Flow	6,276,000	9,511,000	77	61,213,000	69,512,000
Summary
Free Cash Flow	-48,204,000	-71,936,000	-104,113,000	-90,688,000	-63,138,000
Net Change in Cash	-41,928,000	-62,425,000	-104,036,000	-29,472,000	6,374,000